BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8608639)

  • 1. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).
    Jawahar S; Moody C; Chan M; Finberg R; Geha R; Chatila T
    Clin Exp Immunol; 1996 Mar; 103(3):408-13. PubMed ID: 8608639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.
    de Vries E; Koene HR; Vossen JM; Gratama JW; von dem Borne AE; Waaijer JL; Haraldsson A; de Haas M; van Tol MJ
    Blood; 1996 Oct; 88(8):3022-7. PubMed ID: 8874200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.
    Grier JT; Forbes LR; Monaco-Shawver L; Oshinsky J; Atkinson TP; Moody C; Pandey R; Campbell KS; Orange JS
    J Clin Invest; 2012 Oct; 122(10):3769-80. PubMed ID: 23006327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
    Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
    Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of Fc gamma RII on human natural killer cells.
    Metes D; Galatiuc C; Moldovan I; Morel PA; Chambers WH; DeLeo AB; Rabinowich H; Schall R; Whiteside TL; Sulica A
    Nat Immun; 1994; 13(6):289-300. PubMed ID: 7894200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.
    Lenart M; Trzyna E; Rutkowska M; Bukowska-Strakova K; Szaflarska A; Pituch-Noworolska A; Szczepanik A; Zembala M; Siedlar M
    Int J Mol Med; 2010 Sep; 26(3):435-42. PubMed ID: 20664961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
    Lanier LL; Kipps TJ; Phillips JH
    J Exp Med; 1985 Dec; 162(6):2089-106. PubMed ID: 2415663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells.
    Karampatzakis A; Brož P; Rey C; Önfelt B; Cruz De Matos GDS; Rycroft D; Ambrose A; Davis DM
    Front Immunol; 2021; 12():641521. PubMed ID: 33796107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells.
    Cone JC; Lu Y; Trevillyan JM; Bjorndahl JM; Phillips CA
    Eur J Immunol; 1993 Oct; 23(10):2488-97. PubMed ID: 8405050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.
    Watanabe M; Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Maruyama T; Izawa S; Fujii H
    Dis Esophagus; 2010 Nov; 23(8):675-81. PubMed ID: 20545975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
    Chen Y; You F; Jiang L; Li J; Zhu X; Bao Y; Sun X; Tang X; Meng H; An G; Zhang B; Yang L
    Oncotarget; 2017 Jun; 8(23):37128-37139. PubMed ID: 28415754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
    Congy-Jolivet N; Bolzec A; Ternant D; Ohresser M; Watier H; Thibault G
    Cancer Res; 2008 Feb; 68(4):976-80. PubMed ID: 18281470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F; Lopez-Beltran A; Peña J; Solana R
    Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine secretion and NK cell activity in human ADAM17 deficiency.
    Tsukerman P; Eisenstein EM; Chavkin M; Schmiedel D; Wong E; Werner M; Yaacov B; Averbuch D; Molho-Pessach V; Stepensky P; Kaynan N; Bar-On Y; Seidel E; Yamin R; Sagi I; Elpeleg O; Mandelboim O
    Oncotarget; 2015 Dec; 6(42):44151-60. PubMed ID: 26683521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
    de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
    J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.